Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty. Results of a randomized, double-blind, unfractionated heparin and placebo-controlled, multicenter trial (REDUCE trial). Reduction of Restenosis After PTCA, E (Q34407296)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q63253317)
(P304) 1437-1443
(P407) (Q1860)
(P433) 6
(P478) 28
(P577) Friday, November 1, 1996
(P921) (Q269829)
(Q6934595)
(Q539795)
(Q190016)
(P1433) (Q2984355)
(P1476) "Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty. Results of a randomized, double-blind, unfractionated heparin and placebo-controlled, multicenter trial (REDUCE trial). Reduction of Restenosis After PTCA, E" (language: en)
(P2093) Karsch KR
Preisack MB
Baildon R
Eschenfelder V
Foley D
Garcia EJ
Kaltenbach M
Meisner C
Selbmann HK
Shiu MF
Sujatta M
Bonan R
(P2860) (Q28242220)
(Q72816966)
(Q45219598)
(Q69988649)
(Q67669988)
(Q70056528)
(Q36005236)
(Q70033628)
(Q34563209)
(Q70147507)
(Q72285055)
(Q47414777)
(Q28245560)
(Q45945925)
(Q25938997)
(Q59085680)
(Q93616552)
(Q69206458)
(Q44967160)
(Q71156291)
(Q69296621)
(Q47448997)
(Q47371323)
(Q38326202)
(Q44246864)
(Q67903642)
(Q72209735)
(Q50760744)
(Q34336722)
other details
description scientific article

External Links